Core Scientific (CORZ) Accounts Payables (2021 - 2026)

Core Scientific has disclosed Accounts Payables across 6 years of filings, most recently posting $218.9 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $218.9 million, up 3358.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $218.9 million (up 3358.55% YoY), and the FY2025 annual result was $126.1 million, up 554.59% from the prior year.
• Accounts Payables came in at $218.9 million for Q1 2026 at Core Scientific, up from $126.1 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $218.9 million in Q1 2026 to a low of $6.3 million in Q1 2025.
• The 5-year median for Accounts Payables is $45.5 million (2023), against an average of $75.2 million.
• Across the five-year window, Accounts Payables surged 18028.55% in 2022 and sank 87.55% in 2024, its largest moves.
• Core Scientific's Accounts Payables stood at $53.6 million in 2022, then surged by 188.49% to $154.8 million in 2023, then tumbled by 87.55% to $19.3 million in 2024, then surged by 554.59% to $126.1 million in 2025, then soared by 73.55% to $218.9 million in 2026.
• The last three Accounts Payables figures came in at $218.9 million (Q1 2026), $126.1 million (Q4 2025), and $212.2 million (Q3 2025), per Business Quant data.